Beigene Co. Ltd., of Beijing, appointed RuiRong Yuan chief medical officer and president of global clinical development. Yuan will be responsible for driving the development of the company's portfolio of drug candidates through to regulatory approval, as well as contributing to design and providing overall medical and safety oversight for oncology clinical trials.